Go here to sign the petition to #ShutDownMASS in order to minimize the spread of #coronavirus at Change.org change.org/p/massachusett…

BIDMC Cancer Center and BIDMC Hematology/Oncology Fellowship are elated and proud to celebrate our very own senior fellow Dr. Alm Soravis Osataphan, MD for this incredibly well deserved recognition— may your curiosity and innovation continue to soar and lead us to new heights! Rushad Patell #ASCO25

Thank you Melinda Bachini and Cholangiocarcinoma Foundation for supporting my ASCO YIA application and Conquer Cancer, the ASCO Foundation for funding our study to advance the understanding of cholangiocarcinoma tumor microenvironment. Incredibly grateful for the mentorship from the BI team ML peters, Ioannis Vlachos // @ioavlachos.bsky.social and

The remarkable benefit of exercise was just extended to improved survival after cancer in a randomized trial NEJM #ASCO25 nejm.org/doi/full/10.10…

“Not everything that counts can be counted. Not everything that can be counted, counts.” -Mark Lewis, MD, FASCO In oncology, metrics matter. But meaning or time or values? You can’t quantify those. That’s why shared decision-making isn’t just a buzzword; it’s the ENTIRE point. #ASCO25

Wrapped up heme/onc fellowship today —grateful and excited to stay on as a GI oncology attending at BIDMC ! Sincere thanks to Deepa Rangachari, MD, FASCO and Rushad Patell for your wise counsel, impactful mentorship and unwavering support throughout the journey. 🙏🙏🙏

Immensely proud of and grateful for this village! We gathered to celebrate intelligence, integrity, curiosity, and compassion. Congratulations to our graduating ⁦BIDMC Hematology/Oncology Fellowship⁩ and thank you to our ⁦⁦BIDMC Heme/Onc family. May your stars shine bright always! ⁦⁦

Thank you Erman Akkus for highlighting our MTAP study. Notably, we did not find association between OS & CDKN2A/B loss when MTAP was intact – raising an importance ❓ if CDKN2A/B mutations are bystanders and the biological roles of these 3 proteins in CCA progression Cholangiocarcinoma Foundation

Prognostic Role of MTAP Loss in Cholangiocarcinoma: brnw.ch/21wUjbD Authored by Alm Soravis Osataphan, MD et al.

Rigorous,goal-concordant career development is a mandate for modern training and sustenance of our work force to meet patients’ and society’s needs. Check out our latest work on training for community-based careers: ascopubs.org/doi/10.1200/OP… #HemOncMedEd ASCO Rushad Patell